Cao H, Qiu C, Fang A, Shang J, Xu W, He L
Nucleic Acids Res. 2025; 53(2).
PMID: 39797737
PMC: 11724361.
DOI: 10.1093/nar/gkae1304.
Sun X, Zhang H, Jia Y, Li J, Jia M
Eng Microbiol. 2024; 4(3):100154.
PMID: 39629108
PMC: 11611024.
DOI: 10.1016/j.engmic.2024.100154.
Kumar R, Das S, Choudhury B, Kumar A, Prakash N, Verma R
Biol Res. 2024; 57(1):80.
PMID: 39506826
PMC: 11542492.
DOI: 10.1186/s40659-024-00562-6.
Hockemeyer K, Sakellaropoulos T, Chen X, Ivashkiv O, Sirenko M, Zhou H
Nat Cell Biol. 2024; 26(10):1734-1744.
PMID: 39223375
DOI: 10.1038/s41556-024-01490-z.
Ishii M, Yamada T, Ohata S
AMB Express. 2024; 14(1):96.
PMID: 39215862
PMC: 11365917.
DOI: 10.1186/s13568-024-01755-8.
Gene editing therapy for cardiovascular diseases.
Wu X, Yang J, Zhang J, Song Y
MedComm (2020). 2024; 5(7):e639.
PMID: 38974714
PMC: 11224995.
DOI: 10.1002/mco2.639.
Characterization and regulation of cell cycle-independent noncanonical gene targeting.
Saito S, Adachi N
Nat Commun. 2024; 15(1):5044.
PMID: 38890315
PMC: 11189520.
DOI: 10.1038/s41467-024-49385-9.
Recent advances in the characterization of essential genes and development of a database of essential genes.
Liang Y, Luo H, Lin Y, Gao F
Imeta. 2024; 3(1):e157.
PMID: 38868518
PMC: 10989110.
DOI: 10.1002/imt2.157.
Recent Therapeutic Gene Editing Applications to Genetic Disorders.
Deneault E
Curr Issues Mol Biol. 2024; 46(5):4147-4185.
PMID: 38785523
PMC: 11119904.
DOI: 10.3390/cimb46050255.
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine.
Sharma A, Giri A
Front Genet. 2024; 15:1309175.
PMID: 38725484
PMC: 11079134.
DOI: 10.3389/fgene.2024.1309175.
Physiological basis for xenotransplantation from genetically modified pigs to humans.
Peterson L, Yacoub M, Ayares D, Yamada K, Eisenson D, Griffith B
Physiol Rev. 2024; 104(3):1409-1459.
PMID: 38517040
PMC: 11390123.
DOI: 10.1152/physrev.00041.2023.
Precise genome-editing in human diseases: mechanisms, strategies and applications.
Zheng Y, Li Y, Zhou K, Li T, VanDusen N, Hua Y
Signal Transduct Target Ther. 2024; 9(1):47.
PMID: 38409199
PMC: 10897424.
DOI: 10.1038/s41392-024-01750-2.
Post-genomic era in agriculture and veterinary science: successful and proposed application of genetic targeting technologies.
Mazloum A, Karagyaur M, Chernyshev R, Schalkwyk A, Jun M, Qiang F
Front Vet Sci. 2023; 10:1180621.
PMID: 37601766
PMC: 10434572.
DOI: 10.3389/fvets.2023.1180621.
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.
Ma H, Li Q, Wong W, NDiaye E, Caplazi P, Bender H
Sci Adv. 2023; 9(21):eadf0133.
PMID: 37235663
PMC: 10219590.
DOI: 10.1126/sciadv.adf0133.
How molecular techniques are developed from natural systems.
Ronai I
Genetics. 2023; 224(3).
PMID: 37184565
PMC: 10324945.
DOI: 10.1093/genetics/iyad067.
Transgenesis and Genome Engineering: A Historical Review.
Montoliu L
Methods Mol Biol. 2023; 2631:1-32.
PMID: 36995662
DOI: 10.1007/978-1-0716-2990-1_1.
Obligate role for Rock1 and Rock2 in adult stem cell viability and function.
Sambandam A, Storm E, Tauc H, Hackney J, Garfield D, Caplazi P
Heliyon. 2023; 9(3):e14238.
PMID: 36950615
PMC: 10025895.
DOI: 10.1016/j.heliyon.2023.e14238.
The history, use, and challenges of therapeutic somatic cell and germline gene editing.
Ryu J, Adashi E, Hennebold J
Fertil Steril. 2023; 120(3 Pt 1):528-538.
PMID: 36878350
PMC: 10477338.
DOI: 10.1016/j.fertnstert.2023.02.040.
Rare immune diseases paving the road for genome editing-based precision medicine.
Pavel-Dinu M, Borna S, Bacchetta R
Front Genome Ed. 2023; 5:1114996.
PMID: 36846437
PMC: 9945114.
DOI: 10.3389/fgeed.2023.1114996.
Precise and heritable gene targeting in rice using a sequential transformation strategy.
Zhang W, Wang R, Kong D, Peng F, Chen M, Zeng W
Cell Rep Methods. 2023; 3(1):100389.
PMID: 36814841
PMC: 9939429.
DOI: 10.1016/j.crmeth.2022.100389.
